Related Experiment Video
Updated: Jul 20, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Predictive ability of serum osmolarity for contrast-induced nephropathy after elective percutaneous coronary
Ahmad Samir1, Aly Radwan2, Hossam Elhossary2
1Kasr AlAiny Faculty of Medicine, Cairo University, Cairo, Egypt. Ahmad.samir@kasralainy.edu.eg.
Insights
Serum osmolarity is a practical tool to predict contrast-induced nephropathy (CIN) risk in high-risk patients undergoing procedures like percutaneous coronary intervention (PCI). Higher osmolarity, CHA2DS2VA score, and contrast volume independently predict CIN.
Area of Science:
- Cardiology
- Nephrology
- Medical Imaging
Background:
- Contrast-induced nephropathy (CIN) is a significant complication after percutaneous coronary intervention (PCI).
- Certain patient groups face a substantially elevated risk of CIN.
- Identifying high-risk individuals is crucial for effective prevention strategies.
Purpose of the Study:
- To investigate serum osmolarity as a predictor of CIN in diabetic patients with heart failure undergoing coronary angiography or PCI.
- To identify independent predictors of CIN in this high-risk cohort.
Main Methods:
- Prospective observational analytic study of 174 eligible patients.
- Inclusion criteria: diabetic patients with heart failure on diuretics scheduled for coronary angiography and/or PCI.
- Data collected included baseline osmolarity, CHA2DS2VA score, and contrast volume.
Main Results:
- CIN occurred in 24.7% of participants.
- Patients with CIN had significantly higher baseline osmolarity.
- Independent predictors of CIN: pre-procedure osmolarity ≥ 302.3 mOsm/L (OR 7.07), higher CHA2DS2VA score (OR 3.99), and larger contrast volume (OR 1.01).
Conclusions:
- Serum osmolarity is a practical tool for stratifying CIN risk in high-risk patients before procedures.
- Further research is needed to determine if targeting specific pre-procedural osmolarity thresholds can reduce post-PCI CIN.
Background:
Contrast-induced nephropathy (CIN) remains a serious complication following percutaneous coronary intervention (PCI), often leading to poor outcomes. Although the overall incidence of CIN is low, the risk can be significantly higher in certain susceptible cohorts.
Results:
This prospective observational analytic study enrolled 174 consecutive eligible patients. The study selectively included diabetic patients with heart failure who are receiving regular diuretic therapy, being scheduled for elective coronary angiography (CAG) and/or PCI. CIN occurred in 24.7% of the study participants. CIN patients had significantly higher baseline osmolarity compared to those who did not develop CIN. After adjusting for other factors, pre-procedure osmolarity ≥ 302.3 mOsm/L, higher CHA2DS2VA score, and larger contrast volume proved to be independent predictors for CIN with an odds ratio and 95% confidence interval of 7.07 (2.47-20.26), 3.99 (2.02-7.9), and 1.01 (1.0-1.014), respectively.
Conclusions:
In patients at high risk for CIN, serum osmolarity can serve as a practical stratification tool for CIN risk before elective CAG or PCI. Future studies should evaluate whether targeting a specific pre-procedural osmolarity threshold can reduce the risk of post-PCI CIN.
More Related Videos
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention

